Sector Alpha

Track where the smart money flows in Indian equities

DashboardWeekly UpdateUploadPipelinePE CyclesBrainAbout

Data updated weekly. Not financial advice.

Sector Alpha
  1. Home
  2. /Momentum
  3. /Pharma - MNC bulk Drugs
  4. /Abbott India Ltd
MomentumDeep Value

Abbott India Ltd: Stock Analysis & Fundamentals

Updated this week

Abbott India Ltd (Pharma - MNC bulk Drugs) — fundamental analysis, earnings data, and key metrics. PE: 36.4. ROE: 35.7%. This stock is not currently in the Nifty 500 momentum outperformers list.

Key Numbers

Current Price
₹26,135
Dividend Yield
1.82%
Market Cap
55.5K Cr
Valuation
N/A

Other Top Pharma - MNC bulk Drugs Stocks Beating Nifty 500

Novartis India Ltd
Weak • 6w streak
+36.4%
← Back to Pharma - MNC bulk DrugsDashboard

Frequently Asked Questions: Abbott India Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Abbott India Ltd's latest quarterly results?

Abbott India Ltd's latest quarterly results (Dec 2025) show

  • PAT Growth YoY: +4.2%
  • Revenue Growth YoY: +6.8%
  • Operating Margin: 27.0%

What is Abbott India Ltd's current PE ratio?

Abbott India Ltd's current PE ratio is 36.4x.

  • Current PE: 36.4x
  • Market Cap: 55.5K Cr
  • Dividend Yield: 1.82%

What is Abbott India Ltd's price-to-book ratio?

Abbott India Ltd's price-to-book ratio is 13.8x.

  • Price-to-Book (P/B): 13.8x
  • Book Value per Share: ₹1888
  • Current Price: ₹26135

Is Abbott India Ltd a fundamentally strong company?

Abbott India Ltd's fundamental strength based on key financial ratios

  • Return on Capital (ROCE): 46.0%

Is Abbott India Ltd debt free?

Abbott India Ltd has a debt-to-equity ratio of N/A.

  • Total Debt: ₹182 Cr

What is Abbott India Ltd's return on equity (ROE) and ROCE?

Abbott India Ltd's return ratios over recent years

  • FY2023: ROCE 41.0%
  • FY2024: ROCE 46.0%
  • FY2025: ROCE 46.0%

Is Abbott India Ltd's cash flow positive?

Abbott India Ltd's operating cash flow is positive (FY2025).

  • Cash from Operations (CFO): ₹1,000 Cr
  • Free Cash Flow (FCF): ₹1,000 Cr
  • CFO/PAT Ratio: 72% (adequate)

What is Abbott India Ltd's dividend yield?

Abbott India Ltd's current dividend yield is 1.82%.

  • Dividend Yield: 1.82%
  • Current Price: ₹26135

Who holds Abbott India Ltd shares — promoters, FII, DII?

Abbott India Ltd's shareholding pattern (Dec 2025)

  • Promoters: 75.0%
  • FII (Foreign): 0.2%
  • DII (Domestic): 9.0%
  • Public: 15.8%

Is promoter holding increasing or decreasing in Abbott India Ltd?

Abbott India Ltd's promoter holding has remained stable recently.

  • Current Promoter Holding: 75.0% (Dec 2025)
  • Previous Quarter: 75.0% (Sep 2025)
  • Change: 0.00% (stable)

Is Abbott India Ltd a new momentum entry or an established outperformer?

Abbott India Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.

Is Abbott India Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Abbott India Ltd may be worth studying

  • Cash flow is positive — CFO ₹1,000 Cr

What is the investment thesis for Abbott India Ltd?

Abbott India Ltd investment thesis summary:

What is the future outlook for Abbott India Ltd?

Abbott India Ltd's forward outlook based on current data signals

  • Insufficient data for a forward assessment — monitoring for more signals

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.